img

Global Mononucleosis Diagnostic Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Mononucleosis Diagnostic Market Insights, Forecast to 2034

Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.
Market Analysis and InsightsGlobal Mononucleosis Diagnostic Market
Global Mononucleosis Diagnostic market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Mononucleosis Diagnostic industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Mononucleosis Diagnostic market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Mononucleosis Diagnostic market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
ELITechGroup
Beckman Coulter
Bio-Rad Laboratories
Cardinal Health
Immunostics
Meridian Bioscience
Quidel Corporation
Sekisui Diagnostics
Thermo Fischer Scientific
Siemens
Biomerieux
Segment by Type
Monospot Test
Complete Blood Count Test
Epstein Barr Virus (EBV) Antibody Test

Segment by Application


Hospitals
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Mononucleosis Diagnostic introduction, etc. Mononucleosis Diagnostic Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Mononucleosis Diagnostic
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monospot Test
1.2.3 Complete Blood Count Test
1.2.4 Epstein Barr Virus (EBV) Antibody Test
1.3 Market by Application
1.3.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mononucleosis Diagnostic Market Perspective (2018-2033)
2.2 Global Mononucleosis Diagnostic Growth Trends by Region
2.2.1 Mononucleosis Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Mononucleosis Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Mononucleosis Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Mononucleosis Diagnostic Market Dynamics
2.3.1 Mononucleosis Diagnostic Industry Trends
2.3.2 Mononucleosis Diagnostic Market Drivers
2.3.3 Mononucleosis Diagnostic Market Challenges
2.3.4 Mononucleosis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Mononucleosis Diagnostic by Players
3.1.1 Global Mononucleosis Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Mononucleosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mononucleosis Diagnostic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Mononucleosis Diagnostic Market Concentration Ratio
3.4.1 Global Mononucleosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mononucleosis Diagnostic Revenue in 2022
3.5 Global Key Players of Mononucleosis Diagnostic Head office and Area Served
3.6 Global Key Players of Mononucleosis Diagnostic, Product and Application
3.7 Global Key Players of Mononucleosis Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mononucleosis Diagnostic Breakdown Data by Type
4.1 Global Mononucleosis Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Mononucleosis Diagnostic Forecasted Market Size by Type (2024-2033)
5 Mononucleosis Diagnostic Breakdown Data by Application
5.1 Global Mononucleosis Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Mononucleosis Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Mononucleosis Diagnostic Market Size (2018-2033)
6.2 North America Mononucleosis Diagnostic Market Size by Type
6.2.1 North America Mononucleosis Diagnostic Market Size by Type (2018-2023)
6.2.2 North America Mononucleosis Diagnostic Market Size by Type (2024-2033)
6.2.3 North America Mononucleosis Diagnostic Market Share by Type (2018-2033)
6.3 North America Mononucleosis Diagnostic Market Size by Application
6.3.1 North America Mononucleosis Diagnostic Market Size by Application (2018-2023)
6.3.2 North America Mononucleosis Diagnostic Market Size by Application (2024-2033)
6.3.3 North America Mononucleosis Diagnostic Market Share by Application (2018-2033)
6.4 North America Mononucleosis Diagnostic Market Size by Country
6.4.1 North America Mononucleosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Mononucleosis Diagnostic Market Size by Country (2018-2023)
6.4.3 North America Mononucleosis Diagnostic Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Mononucleosis Diagnostic Market Size (2018-2033)
7.2 Europe Mononucleosis Diagnostic Market Size by Type
7.2.1 Europe Mononucleosis Diagnostic Market Size by Type (2018-2023)
7.2.2 Europe Mononucleosis Diagnostic Market Size by Type (2024-2033)
7.2.3 Europe Mononucleosis Diagnostic Market Share by Type (2018-2033)
7.3 Europe Mononucleosis Diagnostic Market Size by Application
7.3.1 Europe Mononucleosis Diagnostic Market Size by Application (2018-2023)
7.3.2 Europe Mononucleosis Diagnostic Market Size by Application (2024-2033)
7.3.3 Europe Mononucleosis Diagnostic Market Share by Application (2018-2033)
7.4 Europe Mononucleosis Diagnostic Market Size by Country
7.4.1 Europe Mononucleosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Mononucleosis Diagnostic Market Size by Country (2018-2023)
7.4.3 Europe Mononucleosis Diagnostic Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Mononucleosis Diagnostic Market Size (2018-2033)
8.2 China Mononucleosis Diagnostic Market Size by Type
8.2.1 China Mononucleosis Diagnostic Market Size by Type (2018-2023)
8.2.2 China Mononucleosis Diagnostic Market Size by Type (2024-2033)
8.2.3 China Mononucleosis Diagnostic Market Share by Type (2018-2033)
8.3 China Mononucleosis Diagnostic Market Size by Application
8.3.1 China Mononucleosis Diagnostic Market Size by Application (2018-2023)
8.3.2 China Mononucleosis Diagnostic Market Size by Application (2024-2033)
8.3.3 China Mononucleosis Diagnostic Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Mononucleosis Diagnostic Market Size (2018-2033)
9.2 Asia Mononucleosis Diagnostic Market Size by Type
9.2.1 Asia Mononucleosis Diagnostic Market Size by Type (2018-2023)
9.2.2 Asia Mononucleosis Diagnostic Market Size by Type (2024-2033)
9.2.3 Asia Mononucleosis Diagnostic Market Share by Type (2018-2033)
9.3 Asia Mononucleosis Diagnostic Market Size by Application
9.3.1 Asia Mononucleosis Diagnostic Market Size by Application (2018-2023)
9.3.2 Asia Mononucleosis Diagnostic Market Size by Application (2024-2033)
9.3.3 Asia Mononucleosis Diagnostic Market Share by Application (2018-2033)
9.4 Asia Mononucleosis Diagnostic Market Size by Region
9.4.1 Asia Mononucleosis Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Mononucleosis Diagnostic Market Size by Region (2018-2023)
9.4.3 Asia Mononucleosis Diagnostic Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Mononucleosis Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 ELITechGroup
11.2.1 ELITechGroup Company Details
11.2.2 ELITechGroup Business Overview
11.2.3 ELITechGroup Mononucleosis Diagnostic Introduction
11.2.4 ELITechGroup Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.2.5 ELITechGroup Recent Developments
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Mononucleosis Diagnostic Introduction
11.3.4 Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.3.5 Beckman Coulter Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Mononucleosis Diagnostic Introduction
11.5.4 Cardinal Health Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.5.5 Cardinal Health Recent Developments
11.6 Immunostics
11.6.1 Immunostics Company Details
11.6.2 Immunostics Business Overview
11.6.3 Immunostics Mononucleosis Diagnostic Introduction
11.6.4 Immunostics Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.6.5 Immunostics Recent Developments
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Mononucleosis Diagnostic Introduction
11.7.4 Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.7.5 Meridian Bioscience Recent Developments
11.8 Quidel Corporation
11.8.1 Quidel Corporation Company Details
11.8.2 Quidel Corporation Business Overview
11.8.3 Quidel Corporation Mononucleosis Diagnostic Introduction
11.8.4 Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.8.5 Quidel Corporation Recent Developments
11.9 Sekisui Diagnostics
11.9.1 Sekisui Diagnostics Company Details
11.9.2 Sekisui Diagnostics Business Overview
11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Introduction
11.9.4 Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.9.5 Sekisui Diagnostics Recent Developments
11.10 Thermo Fischer Scientific
11.10.1 Thermo Fischer Scientific Company Details
11.10.2 Thermo Fischer Scientific Business Overview
11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Introduction
11.10.4 Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.10.5 Thermo Fischer Scientific Recent Developments
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Mononucleosis Diagnostic Introduction
11.11.4 Siemens Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.11.5 Siemens Recent Developments
11.12 Biomerieux
11.12.1 Biomerieux Company Details
11.12.2 Biomerieux Business Overview
11.12.3 Biomerieux Mononucleosis Diagnostic Introduction
11.12.4 Biomerieux Revenue in Mononucleosis Diagnostic Business (2018-2023)
11.12.5 Biomerieux Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Mononucleosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monospot Test
Table 3. Key Players of Complete Blood Count Test
Table 4. Key Players of Epstein Barr Virus (EBV) Antibody Test
Table 5. Global Mononucleosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Mononucleosis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Mononucleosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Mononucleosis Diagnostic Market Share by Region (2018-2023)
Table 9. Global Mononucleosis Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Mononucleosis Diagnostic Market Share by Region (2024-2033)
Table 11. Mononucleosis Diagnostic Market Trends
Table 12. Mononucleosis Diagnostic Market Drivers
Table 13. Mononucleosis Diagnostic Market Challenges
Table 14. Mononucleosis Diagnostic Market Restraints
Table 15. Global Mononucleosis Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Mononucleosis Diagnostic Revenue Share by Players (2018-2023)
Table 17. Global Top Mononucleosis Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2022)
Table 18. Global Mononucleosis Diagnostic Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Mononucleosis Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Mononucleosis Diagnostic, Headquarters and Area Served
Table 21. Global Key Players of Mononucleosis Diagnostic, Product and Application
Table 22. Global Key Players of Mononucleosis Diagnostic, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Mononucleosis Diagnostic Revenue Market Share by Type (2018-2023)
Table 26. Global Mononucleosis Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Mononucleosis Diagnostic Revenue Market Share by Type (2024-2033)
Table 28. Global Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Mononucleosis Diagnostic Revenue Share by Application (2018-2023)
Table 30. Global Mononucleosis Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Mononucleosis Diagnostic Revenue Share by Application (2024-2033)
Table 32. North America Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Mononucleosis Diagnostic Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Mononucleosis Diagnostic Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Mononucleosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Mononucleosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Mononucleosis Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Mononucleosis Diagnostic Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Mononucleosis Diagnostic Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Mononucleosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Mononucleosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Mononucleosis Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Mononucleosis Diagnostic Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Mononucleosis Diagnostic Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Mononucleosis Diagnostic Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Mononucleosis Diagnostic Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Mononucleosis Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Mononucleosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Mononucleosis Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Mononucleosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Mononucleosis Diagnostic Product
Table 67. Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 68. Abbott Laboratories Recent Developments
Table 69. ELITechGroup Company Details
Table 70. ELITechGroup Business Overview
Table 71. ELITechGroup Mononucleosis Diagnostic Product
Table 72. ELITechGroup Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 73. ELITechGroup Recent Developments
Table 74. Beckman Coulter Company Details
Table 75. Beckman Coulter Business Overview
Table 76. Beckman Coulter Mononucleosis Diagnostic Product
Table 77. Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 78. Beckman Coulter Recent Developments
Table 79. Bio-Rad Laboratories Company Details
Table 80. Bio-Rad Laboratories Business Overview
Table 81. Bio-Rad Laboratories Mononucleosis Diagnostic Product
Table 82. Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 83. Bio-Rad Laboratories Recent Developments
Table 84. Cardinal Health Company Details
Table 85. Cardinal Health Business Overview
Table 86. Cardinal Health Mononucleosis Diagnostic Product
Table 87. Cardinal Health Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 88. Cardinal Health Recent Developments
Table 89. Immunostics Company Details
Table 90. Immunostics Business Overview
Table 91. Immunostics Mononucleosis Diagnostic Product
Table 92. Immunostics Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 93. Immunostics Recent Developments
Table 94. Meridian Bioscience Company Details
Table 95. Meridian Bioscience Business Overview
Table 96. Meridian Bioscience Mononucleosis Diagnostic Product
Table 97. Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 98. Meridian Bioscience Recent Developments
Table 99. Quidel Corporation Company Details
Table 100. Quidel Corporation Business Overview
Table 101. Quidel Corporation Mononucleosis Diagnostic Product
Table 102. Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 103. Quidel Corporation Recent Developments
Table 104. Sekisui Diagnostics Company Details
Table 105. Sekisui Diagnostics Business Overview
Table 106. Sekisui Diagnostics Mononucleosis Diagnostic Product
Table 107. Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 108. Sekisui Diagnostics Recent Developments
Table 109. Thermo Fischer Scientific Company Details
Table 110. Thermo Fischer Scientific Business Overview
Table 111. Thermo Fischer Scientific Mononucleosis Diagnostic Product
Table 112. Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 113. Thermo Fischer Scientific Recent Developments
Table 114. Siemens Company Details
Table 115. Siemens Business Overview
Table 116. Siemens Mononucleosis Diagnostic Product
Table 117. Siemens Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 118. Siemens Recent Developments
Table 119. Biomerieux Company Details
Table 120. Biomerieux Business Overview
Table 121. Biomerieux Mononucleosis Diagnostic Product
Table 122. Biomerieux Revenue in Mononucleosis Diagnostic Business (2018-2023) & (US$ Million)
Table 123. Biomerieux Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mononucleosis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Mononucleosis Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Monospot Test Features
Figure 4. Complete Blood Count Test Features
Figure 5. Epstein Barr Virus (EBV) Antibody Test Features
Figure 6. Global Mononucleosis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Mononucleosis Diagnostic Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Mononucleosis Diagnostic Report Years Considered
Figure 12. Global Mononucleosis Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Mononucleosis Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Mononucleosis Diagnostic Market Share by Region: 2022 VS 2033
Figure 15. Global Mononucleosis Diagnostic Market Share by Players in 2022
Figure 16. Global Top Mononucleosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Mononucleosis Diagnostic Revenue in 2022
Figure 18. North America Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Mononucleosis Diagnostic Market Share by Type (2018-2033)
Figure 20. North America Mononucleosis Diagnostic Market Share by Application (2018-2033)
Figure 21. North America Mononucleosis Diagnostic Market Share by Country (2018-2033)
Figure 22. United States Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Mononucleosis Diagnostic Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Mononucleosis Diagnostic Market Share by Type (2018-2033)
Figure 26. Europe Mononucleosis Diagnostic Market Share by Application (2018-2033)
Figure 27. Europe Mononucleosis Diagnostic Market Share by Country (2018-2033)
Figure 28. Germany Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Mononucleosis Diagnostic Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Mononucleosis Diagnostic Market Share by Type (2018-2033)
Figure 36. China Mononucleosis Diagnostic Market Share by Application (2018-2033)
Figure 37. Asia Mononucleosis Diagnostic Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Mononucleosis Diagnostic Market Share by Type (2018-2033)
Figure 39. Asia Mononucleosis Diagnostic Market Share by Application (2018-2033)
Figure 40. Asia Mononucleosis Diagnostic Market Share by Region (2018-2033)
Figure 41. Japan Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Mononucleosis Diagnostic Market Share by Country (2018-2033)
Figure 51. Brazil Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Mononucleosis Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 58. ELITechGroup Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 59. Beckman Coulter Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 61. Cardinal Health Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 62. Immunostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 63. Meridian Bioscience Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 64. Quidel Corporation Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 65. Sekisui Diagnostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 66. Thermo Fischer Scientific Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 67. Siemens Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 68. Biomerieux Revenue Growth Rate in Mononucleosis Diagnostic Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed